Log in

The causal association between peripheral blood eosinophils and nasal polyps: a Mendelian randomization study

  • Short Communication
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Objective

Observational studies suggested that peripheral blood eosinophils were associated with the risk of nasal polyps. However, these studies did not confirm the causality. This study aims to apply Mendelian randomization (MR) method to comprehensively assess the potential causal association between peripheral blood eosinophils and nasal polyps.

Methods

Genetic instrumental variables were extracted from the largest available genome-wide association study (GWAS) of European participants, which were used to investigate the relationship between peripheral blood eosinophils and nasal polyps. The inverse variance weighted method, the MR Egger method, and the weighted median method were applied for this analysis. MR-Egger intercept tests, leave-one-out analyses, and funnel plots were performed for the sensitivity analysis.

Results

With the inverse variance weighted method, the MR analysis suggested that there was a significant difference between peripheral blood eosinophils and the risk of nasal polyps (ukb-a-97, OR 1.004, 95% CI 1.003–1.005, p < 0.001; ukb-a-541, OR 1.005, 95% CI 1.004–1.006, p < 0.001; ukb-b-7211, OR 1.004, 95% CI 1.003–1.005, p < 0.001; ukb-b-8425, OR 1.004, 95% CI 1.003–1.005, p < 0.001; finn-b-J10_NASALPOLYP, OR 3.089, 95% CI 2.537–3.761, p < 0.001). Consistent results were also proved by using the weighted median method and the MR Egger method.

Conclusions

Our findings reveal the causal effect of peripheral blood eosinophils on the increased risk of nasal polyps.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2

Data availability

Not applicable.

References

  1. Hopkins C (2019) Chronic rhinosinusitis with nasal polyps. N Engl J Med 381:55–63

    Article  PubMed  Google Scholar 

  2. Bachert C, Han JK, Desrosiers M et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394:1638–1650

    Article  CAS  PubMed  Google Scholar 

  3. Agache I, Song Y, Alonso-Coello P et al (2021) Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy 76:2337–2353

    Article  CAS  PubMed  Google Scholar 

  4. Pongdee T, Bielinski SJ, Decker PA, Kita H, Larson NB (2022) White blood cells and chronic rhinosinusitis: a Mendelian randomization study. Allergy Asthma Clin Immunol 18:98

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Luo Q, Zhou S, Yuan B et al (2023) Blood eosinophil count in the diagnosis of allergic-like rhinitis with chronic rhinosinusitis. Clin Otolaryngol 48:339–346

    Article  PubMed  Google Scholar 

  6. Delemarre T, Holtappels G, De Ruyck N et al (2020) Type 2 inflammation in chronic rhinosinusitis without nasal polyps: Another  relevant endotype. J Allergy Clin Immunol 146:337–343

    Article  CAS  PubMed  Google Scholar 

  7. Wang Z, Wang Q, Duan S et al (2022) A diagnostic model for predicting type 2 nasal polyps using biomarkers in nasal secretion. Front Immunol 13:1054201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gevaert P, Lang-Loidolt D, Lackner A et al (2006) Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118:1133–1141

    Article  CAS  PubMed  Google Scholar 

  9. Davies NM, Holmes MV, Davey SG (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27:1133–1163

    Article  PubMed  Google Scholar 

  11. Richmond RC, Davey SG (2022) Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med 12:a040501

    Article  PubMed  Google Scholar 

  12. Skrivankova VW, Richmond RC, Woolf B et al (2021) Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326:1614–1621

    Article  PubMed  Google Scholar 

  13. Zhang Z, Li G, Yu L et al (2022) Causal relationships between potential risk factors and chronic rhinosinusitis: a bidirectional two-sample Mendelian randomization study. Eur Arch Otorhinolaryngol 280:2785–2793

    Article  PubMed  PubMed Central  Google Scholar 

  14. Park S, Lee S, Kim Y et al (2021) Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study. Eur Heart J 42:2816–2823

    Article  PubMed  Google Scholar 

  15. Wei Y, Zhan Y, Carlsson S (2023) Childhood adiposity and novel subtypes of diabetes in adults: a Mendelian randomisation and genome-wide genetic correlation study. Lancet Glob Health 11(Suppl 1):S1

    Article  PubMed  Google Scholar 

  16. Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318:1925–1926

    Article  PubMed  Google Scholar 

  17. Seah JJ, Thong M, Wang Y (2023) The diagnostic and prognostic role of biomarkers in chronic rhinosinusitis. Diagnostics (Basel) 13:715

    Article  CAS  PubMed  Google Scholar 

  18. Deng J, Wang Z, Xu Z et al (2023) Blood eosinophils to direct oral corticosteroid treatment for patients with nasal polyps - an open label, non-inferiority, randomized control trial. Rhinology. https://doi.org/10.4193/Rhin22.328

    Article  PubMed  Google Scholar 

  19. Benson VS, Fu Q, Yang S et al (2023) Real-world characterisation of patients with chronic rhinosinusitis with nasal polyps with and without surgery in England. Clin Otolaryngol. https://doi.org/10.1111/coa.14070

    Article  PubMed  Google Scholar 

  20. Bachert C, Han JK, Desrosiers MY et al (2022) Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol 149:1309–1317

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

We are grateful to Dr. Hui-Zi Li for his technical support.

Author information

Authors and Affiliations

Authors

Contributions

G-J Huang, Z-J Fan, and S-H Li performed the conception and designed this manuscript. G-J Huang and Z-Q Chen performed data analysis and prepared the figure. G-J Huang drafted the manuscript. Z-J Fan and S-H Li revised the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Zhi-Jun Fan or Shao-Hua Li.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest in the work.

Ethical approval

Ethics approval or patient written informed consent were not required because the data were extracted from the public databases.

Informed consent

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 519 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, GJ., Chen, ZQ., Fan, ZJ. et al. The causal association between peripheral blood eosinophils and nasal polyps: a Mendelian randomization study. Eur Arch Otorhinolaryngol 280, 4285–4290 (2023). https://doi.org/10.1007/s00405-023-08129-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-023-08129-z

Keywords

Navigation